Ovulation Inducing Drugs Market: Rise in Number of Patients Opting for IVF is Likely to Fuel the Growth Market – BioSpace

Skip to main content
Published: Apr 04, 2022
Albany NY, United States: Changing lifestyle, medicinal adverse effects, delayed pregnancy, and comorbidities are affecting natural reproduction among the human population. These factors have led to the adoption of in vitro fertilization (IVF) or assisted reproductive treatments across the globe. A woman’s ovary produces a single egg in a menstrual cycle.
Read Report Overview – https://www.transparencymarketresearch.com/ovulation-inducing-drugs-market.html
In IVF, eggs are extracted and fertilized in a laboratory to create zygotes. These zygotes are then cultured in a controlled environment. On attaining the blastocyst stage, these embryos are then transferred to uterus. Physicians insist on extracting maximum number of eggs due to low volatility and high failure rates in fertilization and other IVF procedures. Various medications including pharmaceutical preparations and hormones are administered to induce ovulation and increase egg count.
Prior to recommending IVF, physicians promote natural pregnancy. In some cases, infertility is even linked to abnormality or deficiency in ovulation or egg production. Ovulation inducing medications augment the chances of pregnancy, as these tend to increase the egg count, thereby increasing fertilization possibilities. Ovulation stimulation is one of the first and critical steps in IVF.
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=44964
Rise in number of patients opting for IVF is likely to fuel the growth of the global ovulation inducing drugs market during the forecast period from 2018 to 2026. Moreover, key suppliers are introducing new medications such as recombinant hormones and gonadotropins. This is likely to fuel the growth of the ovulation inducing drugs market. However, high cost of IVF procedure and low success rates are the major factors likely to restrain the global ovulation inducing drugs market. Furthermore, large number of small and medium scale manufacturers of ovulation inducing drugs at regional levels has led to a fragmented ovulation inducing drugs market.
The global ovulation inducing drugs market can be segmented based on drug class, distribution channel, and region. In terms of drug class, the global ovulation inducing drugs market can be bifurcated into hormones and pharmaceuticals. The hormones segment can be classified into follicle stimulating hormone (FSH), human menopausal gonadotropin (hMG), and human chorionic gonadotropin (hCG). hMGs are combination of FSH and luteinizing hormone (LH) offering better efficiency and low adverse effects.
Get COVID-19 Analysis on Ovulation Inducing Drugs Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=44964
The pharmaceuticals segment can be divided into gonadotropin releasing hormone (GnRH) agonists and GnRH antagonists. These drugs stimulate the production of gonadotropin hormones such a FSH and LH to augment the ovulation process. Based on distribution channel, the global ovulation inducing drugs market can be segregated into hospital pharmacies, independent pharmacies, and online pharmacies. In some markets, IVF centers dispense these medications to patients.
In terms of region, the global ovulation inducing drugs market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to account for the largest share of the global ovulation inducing drugs market during the forecast period, due to high adoption of IVF and ART techniques. Europe is anticipated to account for a significant share of the global ovulation inducing drugs market during the forecast period.
Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=44964
Well-established health care infrastructure and trend for fertility tourism in countries in Central and Eastern Europe are the key factors driving the embryo transfer devices market in the region. Increase in expenditure to develop health care infrastructure and rise in private health care expenditure in emerging markets such as China and India are anticipated to boost the market in Asia Pacific. Changing lifestyle and rising rates of infertility are the major factors that contribute to the growth of the ovulation inducing drugs market in developing countries.
Major players operating in the global ovulation inducing drugs market are Sanofi, EMD Serono, Inc., Ferring Pharmaceuticals, Inc., Fresenius Kabi AG, Merck & Co., Inc., Sun Pharmaceuticals Industries Ltd., Serum Institute of India Ltd., and Glenmark Pharmaceuticals Ltd.
Browse more Reports by Transparency Market Research:
Pharmaceutical Excipients Market: The growing bioequivalence sector is flourishing with high prevalence of chronic diseases and increased access to medication, especially through online sales and e-Commerce platforms. Increased R&D spending and emergence of new technologies are bringing about a change in the market for pharmaceutical excipients.
Healthcare Reimbursement Market: Growing patient population, rising prevalence of chronic diseases, initiatives taken by public and private entities, increasing cost of health care which encourages stakeholder’s interest in reimbursement, and rising awareness among people regarding health insurance policies are driving the global healthcare reimbursement market.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/
Back to news
Back to top
© 1985 – 2022 BioSpace.com. All rights reserved. Powered by Madgex Job Board Software


Add a Comment

Your email address will not be published. Required fields are marked *